Otoprotective effect of recombinant erythropoietin in a model of newborn hypoxic-ischemic encephalopathy
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, cilt.77, sa.5, ss.739-746, 2013 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 77 Sayı: 5
- Basım Tarihi: 2013
- Doi Numarası: 10.1016/j.ijporl.2013.01.029
- Dergi Adı: INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.739-746
- Anahtar Kelimeler: Hypoxic-ischemic encephalopathy, Hearing loss, Erythropoietin
- Dokuz Eylül Üniversitesi Adresli: Evet
Özet
Objective: The aim of this study is to test the hypotheses that central auditory pathology as well as inner ear pathology is contributing mechanisms to observed hypoxic-ischemic encephalopathy (HIE) induced hearing loss and that recombinant erythropoietin (rhEPO) will reduce this cellular pathology and attenuate hearing loss.